Hard to Treat Diseases, Inc. (HTDS)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Feb 20, 16:00
More

Hard to Treat Diseases EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HTDS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Nutriband, Inc. Upgrade
Immunovant, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade